BIOMAT Database Logo BIOMAT Database Logo

Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration. 2018

J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Department of Pharmacy, Massachusetts General Hospital, Boston, MA, USA.

OBJECTIVE There is a lack of data regarding therapeutic drug monitoring (TDM) of antitubercular agents in the setting of continuous venovenous haemofiltration (CVVH). We describe TDM results of numerous antitubercular agents in a critically ill patient during CVVH and haemodialysis. METHODS A 49-year-old man was initiated on treatment for disseminated Mycobacterium tuberculosis. During hospital admission, the patient developed critical illness and required renal replacement therapy. TDM results and pharmacokinetic calculations showed adequate serum concentrations of rifampin, ethambutol and amikacin during CVVH and of rifampin, pyrazinamide, ethambutol and levofloxacin during intermittent haemodialysis. CONCLUSIONS The presence of critical illness and renal replacement therapy can induce pharmacokinetic changes that may warrant vigilant TDM to ensure optimal therapy. To our knowledge, this is the first report to describe TDM for several antitubercular agents during CVVH in a critically patient with disseminated M. tuberculosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical
D016903 Drug Monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically. Monitoring, Drug,Therapeutic Drug Monitoring,Drug Monitoring, Therapeutic,Monitoring, Therapeutic Drug

Related Publications

J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration.
August 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Interference of continuous venovenous haemofiltration and drug administration.
January 1995, Anaesthesia,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Drug removal in continuous haemofiltration and haemodialysis.
January 1995, British journal of hospital medicine,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Interference of continuous venovenous haemofiltration with vasoactive drug administration.
August 1994, Anaesthesia,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration.
January 2007, Nursing in critical care,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.
July 2005, The Journal of antimicrobial chemotherapy,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.
April 2011, The Journal of antimicrobial chemotherapy,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.
August 2006, The Journal of antimicrobial chemotherapy,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Continuous arteriovenous haemofiltration and haemodialysis.
June 1993, The Journal of the Association of Physicians of India,
J H Sin, and R H Elshaboury, and R M Hurtado, and A R Letourneau, and R G Gandhi
Cardiac output measurement and continuous venovenous haemofiltration.
December 1993, Anaesthesia,
Copied contents to your clipboard!